Regulations.gov document
Use of Data Monitoring Committees in Clinical Trials; Guidance for Industry; Draft…
Other · FDA-2001-D-0219 · posted Feb 13, 2024
Key facts
| Document ID | FDA-2001-D-0219-0016 |
|---|---|
| Title | Use of Data Monitoring Committees in Clinical Trials; Guidance for Industry; Draft Guidance |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2001-D-0219 |
| Posted | Feb 13, 2024 |
| Comment period opens | Feb 13, 2024 |
| Comments due | Apr 16, 2024 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: